Income Statement (SINOVAC/BIOTECH)

Beijing, April 22, 2025 (GLOBE NEWSWIRE) -- To the Shareholders of Sinovac Biotech Ltd. and Other Stakeholders: The management of Sinovac Biotech Ltd. (NASDAQ: SVA, SINOVAC or the Company) recently … [+4277 chars]...

BEIJING Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, a… [+5557 chars]...

BEIJING Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the Board) issued a public… [+9097 chars]...

Lawyers for public companies across the world may not have expected this, but a recent UK appellate decision on an Antigua and Barbuda company greatly enhanced global shareholder rights.  The reason … [+15258 chars]...

Burlingame, CA, April 21, 2025 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, the global meningococcal vaccines market size is estimated to grow from US$ 4.53 Billion in 202… [+9350 chars]...

Dublin, May 02, 2025 (GLOBE NEWSWIRE) -- The "Influenza Market - Vaccines and Therapeutics" report has been added to ResearchAndMarkets.com's offering. The global influenza market was valued at an e… [+12671 chars]...